IA
VYGR icon

IFP Advisors’s Voyager Therapeutics VYGR Stock Holding History

IFP Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326 Buy
93
+57
+158% +$216 ﹤0.01% 4767
2026
Q1 		$139 Hold
36
– – ﹤0.01% 4687
2025
Q4 		$141 Buy
36
+23
+177% +$102 ﹤0.01% 4540
2025
Q3 		$61 Buy
+13
New +$47 ﹤0.01% 4628
2025
Q2 		– Sell
-25
Closed -$81 – 4289
2025
Q1 		$84 Hold
25
– – ﹤0.01% 3903
2024
Q4 		$142 Buy
+25
New +$161 ﹤0.01% 3896
2020
Q2 		– Sell
-150
Closed -$1.75K – 2968
2020
Q1 		$1K Hold
150
– – ﹤0.01% 2637
2019
Q4 		$2K Hold
150
– – ﹤0.01% 2560
2019
Q3 		$3K Buy
+150
New +$3.15K ﹤0.01% 2590
2019
Q1 		$8K Sell
400
-250
-38% -$3.26K ﹤0.01% 1725
2018
Q4 		$6K Hold
650
– – ﹤0.01% 2786
2018
Q3 		$12K Hold
650
– – ﹤0.01% 2766
2018
Q2 		$13K Sell
650
-100
-13% -$1.98K ﹤0.01% 2751
2018
Q1 		$12K Hold
750
– – ﹤0.01% 2692
2017
Q4 		$12K Buy
750
+100
+15% +$1.71K ﹤0.01% 2729
2017
Q3 		$13K Buy
+650
New +$7.33K ﹤0.01% 2895
2016
Q2 		– Sell
-400
Closed -$8K – 4090
2016
Q1 		$8K Buy
+400
New +$4.54K ﹤0.01% 1723

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

IFP Advisors's VYGR Position: Q2 2026 in Review

IFP Advisors increased its Voyager Therapeutics (VYGR) stake by 158% in Q2 2026, buying an estimated $216 and bringing the position to 93 shares worth $326. The position accounts for ﹤0.01% of the portfolio, ranked #4767.

IFP Advisors first reported a position in VYGR in Q1 2016 and has held it in 17 quarters since. The position peaked at $13K in Q2 2018. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • IFP Advisors held 93 shares of Voyager Therapeutics worth $326 as of Q2 2026.
  • IFP Advisors bought 57 Voyager Therapeutics shares in Q2 2026, an estimated $216.
  • Voyager Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4767 holding.
  • IFP Advisors first reported a position in Voyager Therapeutics in Q1 2016 and has held it in 17 quarters since.
  • IFP Advisors's Voyager Therapeutics position peaked at $13K in Q2 2018.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.